SGLT2 inhibitors reduced heart failure events and cardiovascular death in patients with heart failure, type 2 diabetes, chronic kidney disease, and atherosclerotic cardiovascular disease. These ...

The Trump administration’s broadsides against scientific research have caused unprecedented upheaval at the National Cancer ...